
Publication|Articles|October 7, 2026
- October 2026
- Volume 92
- Issue 10
The Midcareer Money Decisions That Matter Most
Author(s)Tim Ulbrich, PharmD
Fact checked by: Yasmeen Qahwash
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Advertisement
Advertisement
Pharmacists spend the first decade of their career focused on building a strong financial foundation. That often includes establishing a cash flow system, paying down debt, building an emergency fund, starting retirement accounts, and putting the appropriate insurance policies in place. There’s plenty to do, and the priority early on is often simply making progress. Then, at some point, something shifts.
Related to this article

Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.

American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.

A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.

AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.

In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.

Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.

Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
Advertisement
Advertisement

